Neurointervention Login Register My Manuscripts Contact
Instructions for Authors


  • Revised January, 2018

Table of Contents

1. Aims and Scope

Neurointervention, the official journal of the Korean Society of Interventional Neuroradiology, publishes original articles documenting to the interventional neuroradiology biannually in 1st March and 1st September. Neurointervention publishes articles related to research in and the practice of neurovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research.

The journal publishes full-length original papers, reviews, technical notes, pictorial essays, case reports, and letters to the editor. Submitted manuscripts should not contain previously published material and should not be under consideration for publication elsewhere unless specific permission is obtained. The instructions for Neurointerven-tion submissions are in accord with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" of the International Committee of Medical Journal editors (ICMJE; and Korean Association of Medical Jouranal Editors (KAMJE,

2. Research and Publication Ethics

For the policies on the research and publication ethics not stated in these instructions, Guidelines on Good Publication ( or Good Publication Practice Guidelines for Medical Journals ( can be applied.

Conflict of Interest
Conflicts of interest/Disclosure statements, if applicable, must be completed with all submissions using the appropriate electronic form in Contribution rules of Journal homepage or the printed form in the Journal. Disclosure is not intended to prevent authors with potential conflicts of interest from contributing to the Neurointervention; rather it places on record any relationship that may exist with mentioned or competing products or firms. Disclosed information will be held in confidence during the review process and the Editors will determine the nature of any printed disclosure accompanying a published article. Authors are responsible for notifying the Journal of financial arrangements including, but not limited to, agreements for research support, speaker bureaus, consulting, or ownership interests.
Neurointervention defines an "author" as a person whose participation in the work is sufficient for taking public responsibility for all portions of the content. Specifically, all authors should have made substantial contributions to all of the following:
(1) conception and design of the study, acquisition of the data, or analysis and interpretation of the data; (2) drafting of the article or critical revision of the article for important intellectual content; and (3) final approval of the version to be submitted.
If any persons who do not meet above four criteria, they may be placed as contributors in Acknowledgments section. Description of co-first authors or co-corresponding authors is also accepted if corresponding author believes that their roles are equally contributed.
The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal's administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors.
Manuscripts involving examinations of volunteers and patients must include a statement that the trial protocol has been approved by an institutional ethics review board (IRB) and that the subjects gave informed consent thus meets the standards of the Declaration of Helsinki in its revised version that the World Medical Association has developed as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data ( Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable, such that patients. names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal experiments, it is expected that investigators will adhere to the 'Guide for the Care and Use of Laboratory Animals.'
Copyright and Permissions
Neurointervention accepts manuscripts describing original research only. The editorial office of Neurointervention does not accept duplicate submission or redundant publication. Redundant (or duplicate) publication is publication of a paper that overlaps substantially with one already published in print or electronic media as defined by updated ICMJE guidelines regarding allegations of scientific misconduct. If authors believe their manuscript may be redundant, they should ask about this in a letter to the editor accompanying their submission. In that letter, they should explain how their report overlaps with already published material, or how it differs. To help the editor determine the possibility of redundant publication, a copy of such published material may also be included. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.
Clinical Trial Registration
Neurointervention requires investigators to register their clinical trials (other than phase 1 or small device feasibility trials) in a public trials registry. This requirement will lessen the chance of publication bias by making all trials (published or unpublished) available to clinicians, investigators, and the public, even those that are negative or reflect unfavorably on a research sponsor's product
Editorial Policies
Manuscripts are examined by the editor and usually evaluated by peer reviewers assigned by the editor. Both clinical and basic articles will also be subject to statistical review, when appropriate. Provisional or final acceptance is based on originality, scientific content, and topical balance of the journal. Manuscript decisions are based on the results of peer review, and to ensure that unbiased reviewers receive manuscripts with blind title pages. Decisions are communicated by email, generally within eight weeks. All rebuttals must be submitted in writing to the editorial office. Descriptions appearing in each article are the responsibility of the author and not of Neurointervention. Editorial board will continuously work for monitoring publication ethics and check manuscripts to confirm the originality.

3. Language, Units and Abbreviations

Official language of this journal is English. For medical terms such as proper nouns, generic names of medicines, and units of measurement, use the original term. Abbreviations should be spelled out when first used in the text─ for example, "dural arteriovenous fistula (DAVF)"─ and the use of abbreviations should be kept to a minimum. In general, only standard abbreviations will be used. Radiation measurements and laboratory values should be in accordance with the International System of Units (SI) (resources: SI Units in Radiation Protection and Measurements, NCRP Report no. 82 [August 1985]; "Now Read This: The SI Units Are Here," JAMA1986;255:2329-2339.

4. Submission of Manuscripts

Electronic submission is the only method of submitting manuscripts to the Neurointervention. Authors must go to and log on for an electronic submission. Hard copy submissions will not be considered.
Manuscripts should preserve anonymity by ensuring that the authors' names appear only on the title page (which should be a separate electronic file) and by eliminating references to institutions, affiliations, and previous work by the authors (stated as such in the manuscript). Authors should organize the manuscript as follows: title page (separate file), blind title page (title only), abstract, introduction, materials and methods, results, discussion, acknowledgments, references, tables, and figure legends.
Upon submission of a manuscript, authors should send a copyright transfer form ( by upload to e-submission system, email or Fax to editorial office.

Dae Chul Suh, M.D., Ph.D.: Editor-in-Chief,
Editorial Office of Neurointervention,
705-2, 9 Gangnam-ro, Giheung-gu, Yongin-si, Gyeonggi-do 16977, KOREA
Tel: +82-31-994-4382
Fax: +82-70-4009-3667
e-mail: or

5. General Guideline for Major Papers

Title: Titles should be short, specific, and informative. A separate running title within eight words should be provided.
Abstract: Use a separate page, and observe a limit of 350 words. Clearly state the purpose, materials (or subjects) and methods, results, and conclusion of the study. Include actual data.
Introduction: Briefly describe the purpose of the investigation, including relevant background information.
Materials and Methods: Describe the research plan, the materials (or subjects), and the methods used, in that order. Explain in detail how the disease was confirmed and how subjectivity in observations was controlled. When experimental methodology is the main issue of the paper, describe the process in detail so as to recreate the experiment as closely as possible.
Present these in a clear, logical sequence. Because biometrics involves variations in exact measurements, follow the rule of using statistics when experimentation is described. If tables are used, do not duplicate tabular data in the text, but do describe important trends and points.
Discussion: Observations pertaining to the results of research and other related materials should be interpreted for your readers. Emphasize new and important observations; do not merely repeat the contents of the results.
Explain the meaning of the observed opinion along with its limits, and within the limits of the research results connect the conclusion to the purpose of the research. In a concluding paragraph, summarize the results and their meaning.
All references should be cited in the text. References are numbered consecutively in the order in which they appear in the text. All references must be cited in the text in parenthesis.

6. Detailed Guideline for Each Type of Manuscripts

After the completion of the manuscript according to checklist, the manuscript and a set of matched figures should be submitted with the Author Contribution Form and the Transfer of Copyright and Certifications Agreement with the signatures of all authors. Forms are automatically sent via email immediately after manuscript submission.

Original Paper

General Guidelines
  • • The manuscript for a major paper should be organized in the following order: title page, blind title page (title only), abstract, introduction, materials and methods, results, discussion, acknowledgements, references, tables, figure legends, and figures.
  • • All manuscript pages are to be numbered consecutively, beginning with the abstract as page 1. Neither the authors' names nor their affiliations should appear on the manuscript pages.
  • • The use of acronyms and abbreviations is discouraged and should be kept to a minimum. When used, they are to be defined where first used, followed by the acronym or abbreviation in parentheses.
  • • The names and locations (city and state only) of manufacturers of equipment and non-generic drugs should be given.
  • • When quoting from other sources, give a reference number in parenthesis after the author's name or at the end of the quotation.
Title Page
The following items should be written on the title page: the title of the thesis, -the running title, and the name of the principal and other authors, along with current positions. When authors with a different address are included, first write the name of the organization where the primary research was conducted and the names of the other organizations along with the authors' names, listed in numerical order, with the numbering system beginning at the first organization. At the bottom of the title page, write the principal author's address, phone, fax and e-mail address, and if necessary, state the source of any research funding. On the blind title page, write only the title of the manuscript. Do not include the authors' names, or other details.
Describe each item separately in the following order.
Purpose: In one or two sentences, indicate the specific purpose of the article, and indicate why it is worthy of attention. The purpose stated here must be identical to the one given in the title of the paper and the introduction.
Materials and Methods: Describe succinctly the methods used to achieve the purpose explained in the first paragraph, stating what was done and how bias was controlled, what data were collected, and how the data were analyzed.
Results: The findings of the methods described in the preceding paragraph are to be presented here, with specific data. All results should flow logically from the methods described.
Conclusion: In one or two sentences, state the conclusion of the study. This must relate directly to the purpose of the papers, as defined in the first paragraph of the abstract.
Do not use reference citations.
At the bottom of the abstract, write 3-6 index terms, according to the index words referred in Medical Subject Heading (MeSH) in Index Medicus, or in internet site,
  • •Start on a separate page, numbering the references consecutively in the order in which they appear in the text.
  • •Unpublished data should not be cited in the reference list, but parenthetically in the text, for example: (Smith DJ, personal communication), (Smith DJ, unpublished data).
  • •Journal names should be abbreviated according to the Index Medicus.
  • •All authors are to be listed when six or fewer; when there are seven or more, the first six should be given, followed by 'et al'.
  • •After writing the authors' last names first, the first letter of their first and middle names should be capitalized.
  • •For all references, inclusive page numbers (e.g., 111- 114) are to be given.
  • •Limit references to forty for original article.
  • •The style and punctuation of references should follow the format illustrated in the following examples.
Print journal reference
Munich SA, Tan LA, Nogueira DM, Keigher KM, Chen M, Crowley RW, et al. Mobile real-time tracking of acute stroke patients and instant, secure inter-team communication - the join app. Neurointervention 2017;12:69-76

Publish-Ahead-of-Print reference:
Lauric A, Hippelheuser JE and Malek AM. Critical role of angiographic acquisition modality and reconstruction on morphometric and haemodynamic analysis of intracranial aneurysms. [published online ahead of print Jan 19, 2018] J Neurointerv Surg. 2018.

Lasjaunias PL, Berenstein A, Ter Burgge KG. Surgical neuroangiography: Clinical vascular anatomy and variations, 2nd ed. Heidelberg: Springer; 2001

Chapter in a book
Berenstein A, Lasjaunias PL, Ter Burgge KG. Dural arteriovenous shunts. In: Berenstein A, Lasjaunias PL, Ter Burgge KG. Surgical neuroangiography: Clinical and endovascular treatment aspects in adults, 2nd ed. Heidelberg: Springer, 2004;3-147
  • •For tables, Arabic numerals should be employed. The title of the table should be clearly stated in the form of a paragraph or sentence. The first letters of nouns and adjectives should be capitalized.
  • •Tables should not be longer than one page and must contain at least four lines and two columns of data.
  • •Tables are to be numbered in the order in which they are cited in the text.
  • •Abbreviations should be defined in an explanatory note below each table.
  • •Tables should be self-explanatory and readily comprehensible. Tables from previously published works should not be used.
  • •Explanations for and abbreviations used in tables are included as footnotes. For footnotes, use the following symbols in the following order: *, †, ‡, §, ‖, ¶, ** ,††, ‡‡, etc.
  • •Submit all figures in BMP, JPG, or TIF format, separately from text. Electronic photographs must have a resolution of at least 300 dpi.
  • •All figure parts relating to one patient should have the same figure number. In the case of multiple prints bearing the same number, use English letters after the numerals to indicate the correct order (example: Fig. 1A, Fig.1B). Authors may wish to make written suggestions about the arrangement of illustrations.
  • •Legends should be numbered in the order in which they are cited, using Arabic numerals.
  • •On a separate sheet of paper, write a description.
  • •List all grants pertinent to the paper. In addition, authors must state whether they have any personal or institutional financial interest in drugs, materials, or devices described in their submissions.
  • •Concise acknowledgment of contributors not listed as authors is welcome.
    # Review, technical notes, case report, pictorial essay, letter to editor: General guidelines and author's checklist conformed to the original papers.
Word count: up to 3500 words (excluding tables and illustrations)
Tables / Illustrations: up to 5
References: up to 30


A review article should focus on a specific topic in a scholarly manner and will be published as a commissioned paper at the request of the editorial board.
Word count: up to 5000 words (excluding tables and illustrations)
Tables / Illustrations: up to 10
References: up to 50

Technical Notes

Technical notes are articles with emphasis on the novel technical aspects of the related fields. These should be exclusively educational or technically innovative. It is encouraged to illustrate the procedures or devices specifically and practically so as to share the new techniques among the readers.
Word count: up to 3000 words (excluding tables and illustrations)
Tables / Illustrations: up to 5
References: up to 20

Case Reports

While Neurointervention encourages the submission of fulllength Original Research papers, it will consider the publication of a limited number of concise Case Reports. These should be unusually educational and medically important.
Abstract: This should be limited to 150 words and consist of one paragraph without a separate introduction, subjects and methods, results or conclusion.
Introduction: Without using the title as an introduction, describe briefly the general background and significance of the case study.
Case Report: Describe the case. Write in the past tense.
Discussion: Focus on the specific area which the case emphasizes and avoid lengthy explanations of references.
References: Limit these to ten.
Word count: up to 1500 words (excluding tables and illustrations)
Tables / Illustrations: up to 5
References: up to 20

Pictorial Essay

This is a visual teaching material. Messages are delivered by figures and their legends. As many as 30 figures will be accepted. Introduction defines the scope and summary of paper with one half or less of a page. Headings are used for separation and organization of text.
Word count: up to 2000 words (excluding tables and illustrations)
Tables / Illustrations: up to 30
References: up to 20

Letters to the Editor

Constructive criticism of a specific thesis published by the Korean Society of Interventional Neuroradiology is welcome. Letters dealing with subjects of general interest within the field of radiology or personal opinions on a specific subject within the realm of scientific study may also be accepted. The maximum length of a letter to the editor should be three pages, with a maximum of four references.
Word count: up to 1000 words
References: up to 10

7. Review Process

Upon submission of a manuscript, the board of editors for the Neurointervention will review the paper for appropriateness of content The board of editors reserves the right to edit a manuscript for phrasing, style and overall at any stage prior to publication, while maintaining the scientific accuracy of the manuscript. The reviewed manuscripts are returned back to the corresponding author with comments and recommended revisions. Names and decisions of the referees are masked.

8. Submission of Revised Manuscripts

The revised manuscripts are submitted by e-mail to editorial office with response letter which must indicate clearly what alterations have been made in response to the referees' comments point by point.

9. Introduction for Submission of Accepted Manuscript

Upon acceptance, the corresponding author should send the final version of manuscript and a signed copyright transfer in advance to the Editorial Office by e-mail or fax.

10. Proof Reading

The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.

Copyright© by Korean Society of Interventional Neuroradiology. All right reserved.
(Gugal-dong, Taepyeongyang Praza) #705-2C, 9 Gangnam-ro, Giheung-gu, Yongin-si, Gyeonggi-do 16977, Korea
TEL : +82-2-2269-4382    FAX : +82-2-2269-4380   E-mail :      Powered by M2community